BBWI — Bath & Body Works Share Price
- $5.96bn
- $9.64bn
- $7.43bn
- 83
- 93
- 45
- 86
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 7.98 | ||
PEG Ratio (f) | 9.69 | ||
EPS Growth (f) | 0.83% | ||
Dividend Yield (f) | 3.12% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 8.69 | ||
Price to Sales | 0.81 | ||
EV to EBITDA | 6.1 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 37.64% | ||
Return on Equity | n/a | ||
Operating Margin | 17.59% |
Financial Summary
Year End 3rd Feb | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 5,405 | 6,434 | 7,882 | 7,560 | 7,429 | 7,244.8 | 7,450.85 | -10.91% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -37.69 | +79.48 | +34.54 | -29.95 | +8.28 | -13.66 | +11.39 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Bath & Body Works, Inc. is an omnichannel retailer focused on personal care and home fragrance. The Company sells merchandise through its retail stores in the United States (U.S.) and Canada, and through its websites and other channels, under the Bath & Body Works, White Barn and other brand names. Its international business is conducted through franchise, license and wholesale partners. It offers a range of care and home fragrance, including collections of fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Its products are differentiated through a combination of fragrance, packaging and quality at accessible prices. It also sells products under its sub brands, including White Barn. Its merchandise is sold through about 1,850 Company-operated stores and e-commerce sites in U.S. and Canada, and in 485 stores and 28 e-commerce sites in more than 40 other countries operating under franchise, license and wholesale arrangements.
Directors
- Sarah Nash NEC (67)
- Andrew Meslow CEO (51)
- Wendy Arlin CFO (50)
- James Bersani CEX (61)
- Julie Rosen CEX
- Christopher Cramer COO
- Deon Riley CHO
- Patricia Bellinger IND (60)
- Francis Hondal IND (56)
- Danielle Lee IND (45)
- Michael Morris IND (74)
- Robert Schottenstein IND (68)
- Stephen Steinour IND (62)
- James Symancyk IND
- Last Annual
- February 3rd, 2024
- Last Interim
- August 3rd, 2024
- Incorporated
- March 16th, 1982
- Public Since
- June 10th, 1982
- No. of Shareholders
- 27,000
- No. of Employees
- 8,981
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- New York Stock Exchange
- Shares in Issue
- 219,111,946
- Address
- THREE LIMITED PKWY,, COLUMBUS, 43216
- Web
- https://www.bbwinc.com/
- Phone
- +1 6144157000
- Contact
- Heather Hollander
- Auditors
- Ernst & Young LLP
Upcoming Events for BBWI
Q4 2024 Bath & Body Works Inc Earnings Release
Similar to BBWI
Abercrombie & Fitch Co
New York Stock Exchange
Advance Auto Parts
New York Stock Exchange
aka Brands Holding
New York Stock Exchange
American Eagle Outfitters
New York Stock Exchange
Amer Sports
New York Stock Exchange
FAQ
As of Today at 19:59 UTC, shares in Bath & Body Works are trading at $27.21. This share price information is delayed by 15 minutes.
Shares in Bath & Body Works last closed at $27.21 and the price had moved by -25.08% over the past 365 days. In terms of relative price strength the Bath & Body Works share price has underperformed the S&P500 Index by -40.74% over the past year.
The overall consensus recommendation for Bath & Body Works is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Bath & Body Works dividend yield is 2.94% based on the trailing twelve month period.
Last year, Bath & Body Works paid a total dividend of $0.80, and it currently has a trailing dividend yield of 2.94%. We do not have any data on when Bath & Body Works is to next pay dividends.
We do not have data on when Bath & Body Works is to next pay dividends. The historic dividend yield on Bath & Body Works shares is currently 2.94%.
To buy shares in Bath & Body Works you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $27.21, shares in Bath & Body Works had a market capitalisation of $5.96bn.
Here are the trading details for Bath & Body Works:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: BBWI
Based on an overall assessment of its quality, value and momentum Bath & Body Works is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bath & Body Works is $43.32. That is 59.21% above the last closing price of $27.21.
Analysts covering Bath & Body Works currently have a consensus Earnings Per Share (EPS) forecast of $3.19 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bath & Body Works. Over the past six months, its share price has underperformed the S&P500 Index by -45.42%.
As of the last closing price of $27.21, shares in Bath & Body Works were trading -34.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bath & Body Works PE ratio based on its reported earnings over the past 12 months is 7.98. The shares last closed at $27.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bath & Body Works' management team is headed by:
- Sarah Nash - NEC
- Andrew Meslow - CEO
- Wendy Arlin - CFO
- James Bersani - CEX
- Julie Rosen - CEX
- Christopher Cramer - COO
- Deon Riley - CHO
- Patricia Bellinger - IND
- Francis Hondal - IND
- Danielle Lee - IND
- Michael Morris - IND
- Robert Schottenstein - IND
- Stephen Steinour - IND
- James Symancyk - IND